November 15, 2019
The Master Class XX • 2019
Disclaimer
The recommendations provided from the authors were obtained on November 15, 2019. The opinions and recommendations do not necessarily accurately reflect the current state of affairs or the current advice the authors may choose to provide in the same circumstances. Please refer to the current guidelines or the Canadian Association of Gastroenterology (CAG) for up-to-date treatment options.
Learning Objectives
The educational objective of the Mentoring in IBD XX program is to increase awareness of current developments and best practices in inflammatory bowel disease (IBD) management, promote collaboration among Canadian gastroenterologists, and optimize treatment of IBD.
Participants in this program will be able to:
- Differentiate nutrition as primary therapy for IBD vs. nutritional support and replacement
- Explore new therapies in IBD with emphasis on individualized therapy and strategic sequencing
- Compare endoscopic and radiologic imaging advances in technology for the evaluation of small bowel Crohn’s disease
- Discuss rheumatological manifestations in inflammatory bowel disease
- Examine checkpoint inhibitor colitis, NSAID colopathy and infectious colidites to differentiate IBD mimickers from real IBD
Nutrition Therapy for IBD: A Primer for Adult GI
Presented by Eytan Wine, MD PhD FRCPC
Therapeutics in IBD: Many new choices, but who's on first?
Presented by Brian G. Feagan, MD FRCPC
Technological Advances in IBD
Presented by Bincy Abraham, MD MS AGAF FACG and Luís S. Guimarães, MD PhD
Plenary: Evaluating Small Bowel CD_GI Perspective
Plenary: Evaluating Small Bowel CD - Radiologist Perspective